Zomedica ZOM Stock
Zomedica Price Chart
Zomedica ZOM Financial and Trading Overview
| Zomedica stock price | 0.1 USD |
| Previous Close | 0.19 USD |
| Open | 0.19 USD |
| Bid | 0.19 USD x 1400 |
| Ask | 0.2 USD x 800 |
| Day's Range | 0.19 - 0.2 USD |
| 52 Week Range | 0.15 - 0.41 USD |
| Volume | 3.21M USD |
| Avg. Volume | 3.68M USD |
| Market Cap | 191.29M USD |
| Beta (5Y Monthly) | 0.958802 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.44 USD |
ZOM Valuation Measures
| Enterprise Value | 69.66M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.258325 |
| Price/Book (mrq) | 0.72835815 |
| Enterprise Value/Revenue | 3.372 |
| Enterprise Value/EBITDA | -3.392 |
Trading Information
Zomedica Stock Price History
| Beta (5Y Monthly) | 0.958802 |
| 52-Week Change | -18.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.41 USD |
| 52 Week Low | 0.15 USD |
| 50-Day Moving Average | 0.2 USD |
| 200-Day Moving Average | 0.22 USD |
ZOM Share Statistics
| Avg. Volume (3 month) | 3.68M USD |
| Avg. Daily Volume (10-Days) | 3.43M USD |
| Shares Outstanding | 979.95M |
| Float | 965.81M |
| Short Ratio | 21.26 |
| % Held by Insiders | 1.33% |
| % Held by Institutions | 9.77% |
| Shares Short | 79.23M |
| Short % of Float | 8.19% |
| Short % of Shares Outstanding | 8.08% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -94.20% |
| Operating Margin (ttm) | -121.58% |
| Gross Margin | 71.46% |
| EBITDA Margin | -99.39% |
Management Effectiveness
| Return on Assets (ttm) | -5.63% |
| Return on Equity (ttm) | -7.31% |
Income Statement
| Revenue (ttm) | 20.66M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 46.10% |
| Gross Profit (ttm) | 13.65M USD |
| EBITDA | -20535000 USD |
| Net Income Avi to Common (ttm) | -19463000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 121.05M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 1.58M USD |
| Total Debt/Equity (mrq) | 0.6 USD |
| Current Ratio (mrq) | 15.141 |
| Book Value Per Share (mrq) | 0.268 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13456000 USD |
| Levered Free Cash Flow (ttm) | -9824500 USD |
Profile of Zomedica
| Country | United States |
| State | MI |
| City | Ann Arbor |
| Address | 100 Phoenix Drive |
| ZIP | 48108 |
| Phone | 734 369 2555 |
| Website | https://www.zomedica.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 85 |
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform and VetGuardian, a zero-touch vital signs remote monitoring system, as well as Revo Squared imaging platform comprising diagnostic imaging products and services for use in animal health. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.
Q&A For Zomedica Stock
What is a current ZOM stock price?
Zomedica ZOM stock price today per share is 0.1 USD.
How to purchase Zomedica stock?
You can buy ZOM shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zomedica?
The stock symbol or ticker of Zomedica is ZOM.
Which industry does the Zomedica company belong to?
The Zomedica industry is Drug Manufacturers-Specialty & Generic.
How many shares does Zomedica have in circulation?
The max supply of Zomedica shares is 979.95M.
What is Zomedica Price to Earnings Ratio (PE Ratio)?
Zomedica PE Ratio is 0.00000000 now.
What was Zomedica earnings per share over the trailing 12 months (TTM)?
Zomedica EPS is 0 USD over the trailing 12 months.
Which sector does the Zomedica company belong to?
The Zomedica sector is Healthcare.